Total Payments
$2,719
2024 Payments
$402.71
Companies
28
Transactions
132
Medicare Patients
4,421
Medicare Billing
$185,641
Payment Breakdown by Category
Food & Beverage$2,419 (89.0%)
Education$299.97 (11.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,419 | 129 | 89.0% |
| Education | $299.97 | 3 | 11.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $667.18 | 22 | $0 (2024) |
| Medtronic, Inc. | $361.17 | 16 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $241.61 | 12 | $0 (2024) |
| Janssen Biotech, Inc. | $233.43 | 15 | $0 (2024) |
| Axonics, Inc. | $155.52 | 9 | $0 (2022) |
| Boston Scientific Corporation | $96.78 | 5 | $0 (2023) |
| Blue Earth Diagnostics Limited | $93.04 | 6 | $0 (2022) |
| PFIZER INC. | $90.33 | 5 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $86.82 | 4 | $0 (2024) |
| UROGEN PHARMA, INC. | $81.11 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $402.71 | 18 | Astellas Pharma US Inc ($146.69) |
| 2023 | $734.20 | 32 | Medtronic, Inc. ($234.50) |
| 2022 | $722.43 | 38 | Astellas Pharma US Inc ($172.67) |
| 2021 | $859.98 | 44 | Astellas Pharma US Inc ($220.93) |
All Payment Transactions
132 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/31/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Oncology | ||||||
| 10/07/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/18/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $16.26 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Oncology | ||||||
| 09/12/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $15.48 | General |
| Category: UROLOGY | ||||||
| 09/04/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 09/04/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Oncology | ||||||
| 08/20/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Oncology | ||||||
| 08/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Oncology | ||||||
| 08/06/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Oncology | ||||||
| 07/25/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Oncology | ||||||
| 07/11/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: ONCOLOGY | ||||||
| 07/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/01/2024 | Medtronic, Inc. | NURO (Device) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Tibial Nerve Stimulation | ||||||
| 08/15/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/08/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/08/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $8.39 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/05/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $68.71 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 07/25/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 07/10/2023 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 06/30/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: Sacral Nerve Stimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 884 | 1,180 | $127,520 | $34,185 |
| 2022 | 12 | 1,150 | 17,417 | $149,253 | $50,515 |
| 2021 | 15 | 1,239 | 1,814 | $160,789 | $65,461 |
| 2020 | 11 | 1,148 | 1,423 | $97,802 | $35,480 |
Total Patients
4,421
Total Services
21,834
Medicare Billing
$185,641
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 189 | 224 | $49,550 | $13,982 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 162 | 173 | $26,701 | $8,652 | 32.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 34 | 119 | $17,082 | $3,448 | 20.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $10,901 | $3,095 | 28.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 186 | 199 | $5,300 | $1,286 | 24.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 147 | $10,468 | $1,106 | 10.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $2,678 | $860.41 | 32.1% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 14 | 14 | $2,618 | $648.34 | 24.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 21 | $1,155 | $599.45 | 51.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 205 | 231 | $1,066 | $508.20 | 47.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 236 | 300 | $56,896 | $21,980 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 252 | 299 | $37,611 | $12,936 | 34.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 23 | 152 | $15,179 | $4,850 | 32.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $7,676 | $2,888 | 37.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 248 | 301 | $7,368 | $1,858 | 25.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 29 | 210 | $9,965 | $1,745 | 17.5% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2022 | 16 | 24 | $3,741 | $1,130 | 30.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 259 | 345 | $3,060 | $766.23 | 25.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 17 | $1,759 | $764.84 | 43.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $3,101 | $671.18 | 21.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 18 | 24 | $1,326 | $585.19 | 44.1% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2022 | 11 | 15,700 | $1,570 | $340.83 | 21.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 319 | 412 | $45,141 | $20,600 | 45.6% |
| J3490 | Unclassified drugs | Office | 2021 | 12 | 53 | $30,570 | $14,197 | 46.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 157 | 184 | $28,932 | $13,060 | 45.1% |
About Daniel Pevril
Daniel Pevril is a Family healthcare provider based in Mountain Home, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2019. The National Provider Identifier (NPI) number assigned to this provider is 1649811415.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Pevril has received a total of $2,719 in payments from pharmaceutical and medical device companies, with $402.71 received in 2024. These payments were reported across 132 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,419).
As a Medicare-enrolled provider, Pevril has provided services to 4,421 Medicare beneficiaries, totaling 21,834 services with total Medicare billing of $185,641. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Mountain Home, AR
- Active Since 10/03/2019
- Last Updated 08/13/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1649811415
Products in Payments
- INTERSTIM (Device) $343.03
- ERLEADA (Drug) $187.14
- Xtandi (Drug) $182.02
- XTANDI (Drug) $178.76
- Axonics r-SNM System (Device) $142.12
- BRAC CDx (Device) $108.93
- Axumin (Drug) $93.04
- Nubeqa (Drug) $86.82
- ELIGARD (Drug) $82.25
- JELMYTO (Drug) $81.11
- BOTOX (Biological) $75.12
- ANJESO (Drug) $74.04
- BRACAnalysis CDx (Device) $64.36
- CAMCEVI (Drug) $48.60
- PROLARIS (Device) $47.21
- Myrbetriq (Drug) $44.82
- ORGOVYX (Drug) $43.96
- GEMTESA (Drug) $41.29
- GENTLECATH (Device) $33.38
- KEYTRUDA (Biological) $32.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Mountain Home
Julie Hutchens, Aprn, APRN
Family — Payments: $4,402
Family $4,402
Mrs. Amy Reano, Np-C, NP-C
Family — Payments: $3,497
Family $3,497
Leah Fountain, Msn, Np-C Aprn, MSN, NP-C APRN
Family — Payments: $2,409
Family $2,409
Mrs. Maegan Wagner, Anp, ANP
Family — Payments: $1,906
Family $1,906
Hannah Caststeel, Cnp, CNP
Family — Payments: $1,689
Family $1,689
Mrs. Debra Schulte, Aprn, APRN
Family — Payments: $1,478
Family $1,478